[HTML][HTML] Goals of COPD treatment: Focus on symptoms and exacerbations

CF Vogelmeier, M Roman-Rodriguez, D Singh… - Respiratory …, 2020 - Elsevier
Chronic obstructive pulmonary disease (COPD) is currently a leading cause of death
worldwide, and its burden is expected to rise in the coming years. Common COPD …

Diagnosis and outpatient management of chronic obstructive pulmonary disease: a review

CM Riley, FC Sciurba - Jama, 2019 - jamanetwork.com
Importance There are 30 million adults (12%) in the United States who have chronic
obstructive pulmonary disease (COPD). Chronic obstructive pulmonary disease accounts for …

Choosing the right inhaler for your asthma or COPD patient

OS Usmani - Therapeutics and clinical risk management, 2019 - Taylor & Francis
Appropriate selection and correct use of inhalation devices is an integral component in the
management of asthma and chronic obstructive pulmonary disease (COPD). It is well known …

A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma

I Sulaiman, G Greene, E MacHale… - European …, 2018 - Eur Respiratory Soc
In severe asthma, poor control could reflect issues of medication adherence or inhaler
technique, or that the condition is refractory. This study aimed to determine if an intervention …

[HTML][HTML] Short-term CPAP adherence in obstructive sleep apnea: a big data analysis using real world data

PA Cistulli, J Armitstead, JL Pepin, H Woehrle… - Sleep …, 2019 - ncbi.nlm.nih.gov
1. Background Effective treatment of obstructive sleep apnea (OSA) is an important goal due
to its impact on quality of life, and the known cardiovascular and neurocognitive …

Status of and strategies for improving adherence to COPD treatment

JL López-Campos, E Quintana Gallego… - … journal of chronic …, 2019 - Taylor & Francis
Despite the wide application of adherence as a concept, the definition, evaluation and
improvement of the adherence to treatment by patients with chronic obstructive pulmonary …

Digital healthcare in COPD management: a narrative review on the advantages, pitfalls, and need for further research

A Watson, TMA Wilkinson - Therapeutic Advances in …, 2022 - journals.sagepub.com
Chronic obstructive pulmonary disease (COPD) remains a leading cause of morbidity and
mortality despite current treatment strategies which focus on smoking cessation, pulmonary …

[HTML][HTML] Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic …

EM Jansen, SJ van de Hei, BJH Dierick… - Journal of thoracic …, 2021 - ncbi.nlm.nih.gov
Medication non-adherence to asthma and chronic obstructive pulmonary disease therapy
poses a significant burden for patients and societies. Non-adherence encompasses poor …

Poly (lactic acid)/poly (lactic-co-glycolic acid) particulate carriers for pulmonary drug delivery

F Emami, SJ Mostafavi Yazdi, DH Na - Journal of Pharmaceutical …, 2019 - Springer
Background Pulmonary route is an attractive target for both systemic and local drug delivery,
with the advantages of a large surface area, rich blood supply, and absence of first-pass …

Understanding dry powder inhalers: key technical and patient preference attributes

ML Levy, W Carroll, JL Izquierdo Alonso, C Keller… - Advances in …, 2019 - Springer
Inhalable medications for patients with asthma and chronic obstructive pulmonary disease
(COPD) can be confusing even for health care professionals because of the multitude of …